Skip to content
Open access

[18F]Pamiparib: Synthesis and evaluation of a novel PARP1/2 radiotracer in rodent and nonhuman primate brain.

Oct 2026 · Nuclear Medicine and Biology · Vol 162-163, pp. 109842 · 0 citations · 45 references
Medicine

Abstract

The poly(ADP-ribose) polymerase (PARP) family plays important roles in DNA repair, chromatin organization, genome integrity, apoptosis, and inflammation. PARP1 and PARP2 are validated therapeutic targets that have attracted considerable interests, with multitude of PARP1/2 inhibitors emerged for treatment of cancers, metabolic, inflammatory, and neurological disorders. PARP1/2 are activated by DNA damage caused by inflammatory responses, and are involved in the etiology of various neurological disorders. PARP1/2-targeted noninvasive PET imaging has shown potential in cancer diagnosis and prognosis. However, quantitative PARP1/2 PET imaging in the central nervous system has been challenging, due to the lack of blood-brain barrier (BBB) penetrable PARP1/2 radioligands. This work proposes the use of Pamiparib (BGB-290), a potent PARP-1 and PARP-2 inhibitor, as a lead for potential BBB penetrant PARP1/2 PET tracer. We synthetized [18F]Pamiparib and evaluated its binding specificity using Olaparib, Veliparib, and Saruparib, both in vitro and ex vivo. [18F]Pamiparib PET imaging was performed in nonhuman primate (NHP), with arterial blood sampling and radiometabolite analysis. The in vitro autoradiography results showed higher binding affinity in tumors than in rodent and NHP brain tissues. [18F]Pamiparib possess a higher parent fraction in NHP than in rodents, with similar uptake across brain regions (SUV ~ 0.2). The volume of distribution (VT) values derived from the 1-tissue compartment (1TC) model for [18F]Pamiparib and [11C]PyBic in the same NHP correlated well. In conclusion, [18F]Pamiparib showed relatively low brain penetration and stable regional uptake in NHP, positioning it as a quantitative imaging tool for target engagement of Pamiparib at individual levels and a potential tool for non-invasive quantitative imaging of PARP1/2.

Read PDF

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.